BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for 4D Molecular Therapeutics Inc. Common Stock (FDMT)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: 4D Molecular Therapeutics Inc. Common Stock
Symbol: FDMT
Shares outstanding: 46.4M shares
Disclosed Ownership: 3.62M shares
Ownership: 7.8%
Form type: SCHEDULE 13G/A
Filing time: 17 Apr 2025, 09:35:27 UTC
Date of event: 31 Mar 2025
Next filing: 17 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	7.8%	3.62M	3.58M	0	Spencer Fleming	Managing Director